PT  - JOURNAL ARTICLE
AU  - Karimuzzaman, Md.
AU  - Afroz, Sabrina
AU  - Hossain, Md. Moyazzem
AU  - Rahman, Azizur
TI  - Forecasting the COVID-19 Pandemic with Climate Variables for Top Five Burdening and Three South Asian Countries
AID  - 10.1101/2020.05.12.20099044
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.12.20099044
4099  - http://medrxiv.org/content/early/2020/05/19/2020.05.12.20099044.short
4100  - http://medrxiv.org/content/early/2020/05/19/2020.05.12.20099044.full
AB  - Background The novel coronavirus (COVID-19) is now in a horrific situation around the world. Prediction about the number of infected and death cases may help to take immediate action to prevent the epidemic as well as control the situation of a country. The ongoing debate about the climate factors may need more validation with more studies. The climate factors of the top-five affected countries and three south Asian countries have considered in this study to have a real-time forecast and robust validation about the impact of climate variables.Methods The ARIMA model have included to model the univariate cumulative confirmed and death cases separately. The MLP, ELM and likelihood-based GLM count time series also considered as they consider the external variables as exogenous regressors. As the death count includes zero itself, zero-inflated count time series model has included instead of likelihood-based GLM. The better fitting of the ARIMA model will validate the under-whelm of meteorological factors was the initial hypothesis. The best model has identified through the application and comparison with the real data points.Results The results depict that there is an influence of meteorological variables like temperature and humidity mostly for all the selected countries cumulative confirm cases excluding Italy and Sri-Lanka. However, the best models for deaths count of each country also identify the impact of meteorological variables for each country.Conclusion The authors make the sixty days ahead forecast for each country which will be beneficial for the policymakers.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementThis work was not funded.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be available upon request and/or in an URL.